Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 34.17% is 1178% above its 3-year average of -3.17%, near the high end of its 3-year range (-25.52%–34.17%).
367.84% above its 12-month average of -12.76%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2025 (2025-12-31): 0.00%.
GROSS MARGIN
34.17%
GROSS MARGIN AVG TTM
-12.76%
GROSS MARGIN AVG 3Y
-3.17%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+367.84%
CURRENT VS 3Y AVG
+1177.54%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.63%
median of 782 covered companies
CURRENT VS SECTOR MEDIAN
-15.90%
vs the sector median at left
Moolec Science S.A.
Market Cap
$3.40M
Gross Margin
34.17%
TTM Avg
-12.76%
3Y Avg
-3.17%
5Y Avg
0.00%
Market Cap
$3.29M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.52M
Gross Margin
79.65%
TTM Avg
78.98%
3Y Avg
76.82%
5Y Avg
80.07%
Market Cap
$3.29M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
25.00%
5Y Avg
50.00%
Market Cap
$3.23M
Gross Margin
16.54%
TTM Avg
-251.00%
3Y Avg
-125.05%
5Y Avg
-78.44%
Market Cap
$3.23M
Gross Margin
0.00%
TTM Avg
-310.04%
3Y Avg
-329.59%
5Y Avg
-274.54%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Moolec Science S.A. (MLEC) | $3.40M | 34.17% | -12.76% | -3.17% | 0.00% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.29M | 0.00% | 0.00% | 0.00% | 0.00% |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 0.00% | 0.00% | 0.00% | 0.00% |
| Eocene Ltd. (EOCN)vs › | $3.49M | N/A | N/A | N/A | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.52M | 79.65% | 78.98% | 76.82% | 80.07% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.29M | 0.00% | 0.00% | 25.00% | 50.00% |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.23M | 16.54% | -251.00% | -125.05% | -78.44% |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.23M | 0.00% | -310.04% | -329.59% | -274.54% |
| MBody AI Ltd. (MBAI)vs › | $3.18M | 0.00% | 0.00% | 0.00% | 0.00% |
| IceCure Medical Ltd (ICCM)vs › | $3.13M | 36.10% | 40.19% | 41.87% | 47.28% |
Gross Margin
34.2%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2025-12-31 | 0.00% |
| 2024-12-31 | -25.52% |
| 2024-09-30 | 0.95% |
| 2024-06-30 | -4.70% |
| 2024-03-31 | 4.35% |
| 2023-12-31 | -3.62% |
| 2023-09-30 | 12.67% |
| 2023-06-30 | -15.83% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
